The role and efficacy of Nirmatrelvir/Ritonavir combination (Nirmatrelvir/Ritonavir)

Final data from a study(ERIC-HR Phase 2/3) showed that when the nirmatrelvir/ritonavir tablet combination Paxlovid (Nirmatrelvir/Ritonavir) was taken within 3 days of the onset of symptoms of a new coronavirus infection, it successfully reduced the risk of hospitalization by 89% in patients at high risk of the new coronavirus infection progressing to severe disease. When taken within 5 days of symptoms, the nematvir/ritonavir combination reduces the risk of hospitalization by 88%.

The Nematrevir/Ritonavir tablet combination consists of two co-packaged medicines, Nematrevir (formerly known as PF-07321332) and Ritonavir, and contains oral tablets that are best taken at the first sign of symptoms after a positive Sars-CoV-2 test. Taking it can help reduce the number and severity of symptoms or avoid serious illness that could lead to hospitalization or death. Although there is a possibility of a rebound of novel coronavirus infection, most people who take the nematvir/ritonavir tablet combination for 5 days will recover from the novel coronavirus infection, and there have been no reports of serious consequences related to the rebound of novel coronavirus infection.

NematrevirThe combination of nematvir/ritonavir tablets has been launched in China. Due to its short time on the market, it has not been included in the medical insurance. The domestic price has not yet been determined. The original drug of nematvir/ritonavir tablet combination marketed overseas, the specification is nematvir 150mg + ritonavir 100mg)*30 tablets per box, the price may be around 2,000 yuan (the price may fluctuate due to the exchange rate), India The price of each box of the generic Nematvir/Ritonavir tablet combination produced by the pharmaceutical factory may be around RMB 1,000 (the price may fluctuate due to the exchange rate). The ingredients of the two drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.